![]() |
![]() | ![]() |
We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
![]()
I am a shareholder of Tri-Point Medical Corp (TPMC). This company recently (9/96) went IPO at $8/sh w/12.1M ost. As of 11/27/96 the stock is trading at 10 1/4. This company is attempting to develop a medical-grade adhesive to use as substitute for sutures and staples. Its current core product at this time (TraumaSeal) recently completed clinical trials, and filing for PMA to the FDA is planned at 1Q97. The company has signed strategic partnership with Ethicon (a division of J & J) and is the world leader of surgical closure market. The product is based on cyanoacrylate technology (same as Super Glue) and, IMHO, this product is significantly superior to that of bandage, sutures and staples. Analyst report projects the stock to be at $11 within the short-term and $35 for the long-term. This is not an endorsement to buy or sell. It is provided for information purpose. Let keep an eye on this company.
| ||||||||||||
|
Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
© 2022 Knight Sac Media. Data provided by IEX, Alpha Vantage, Coinbase, Binance, Fintel and CityFALCON News |